Leuprolide Depot Injection 22.5 mg

Leuprolide Depot Injection 22.5 mg
Product Description

Mechanism of Action (MOA): Leuprolide acts as a GnRH agonist, initially stimulating but eventually suppressing LH & FSH secretion, leading to decreased testosterone in men and estrogen in women.
Therapeutic UsProstate Cancer – Advanced and hormone-dependent cases
 Endometriosis – Symptom relief & disease management
 Uterine Fibroids – Pre-surgical reduction of fibroid size
 Central Precocious Puberty (CPP) – Delays early puberty onset

 Key Benefits:
 Sustained-release formulation for long-term efficacy
 Effective hormonal suppression for multiple indications
 Trusted therapy in oncology & gynecology

Swasthya Healthcare Private Limited

  • IN
  • 2022
    On CPHI since
  • 100 - 249
    Employees
Company types
Manufacturer/Innovator
Primary activities
Pharmaceutical Company (generic finished products)

Swasthya Healthcare Private Limited

  • IN
  • 2022
    On CPHI since
  • 100 - 249
    Employees
Company types
Manufacturer/Innovator
Primary activities
Pharmaceutical Company (generic finished products)

More Products from Swasthya Healthcare Private Limited (2)

  • Fingolimod Capsules 0.5 mg

    Product Fingolimod Capsules 0.5 mg

    Fingolimod, a sphingosine-1-phosphate (S1P) receptor modulator, is an effective therapy for Relapsing-Remitting Multiple Sclerosis (RRMS) that reduces relapses, slows disability progression, and enhances patient quality of life.

     Mechanism of Action (MOA): Modulates S1P receptors, which ...
  • Iohexol Injection USP 300mg-50ml

    Product Iohexol Injection USP 300mg-50ml

     Product Overview: Iohexol is widely used in computed tomography (CT) scans, angiography, and urography to improve image clarity, enabling precise diagnosis and treatment planning.

     Key Features:

    High-contrast enhancement for detailed imaging Excellent safety profile with l...

Frequently Viewed Together

Recently Visited